A New Link Between the C-Abl Tyrosine Kinase and Phosphoinositide Signalling Through PLC-gamma1

Overview

Journal Nat Cell Biol

Specialty Cell Biology

Date 2003 Mar 26

PMID 12652307

Citations 56

Authors

Rina Plattner

Brenda J Irvin

Shuling Guo

Kevin Blackburn

Andrius Kazlauskas

Robert T Abraham

John D York

Ann Marie Pendergast

Affiliations

Soon will be listed here.

Abstract

The c-Abl tyrosine (Tyr) kinase is activated after platelet-derived-growth factor receptor (PDGFR) stimulation in a manner that is partially dependent on Src kinase activity. However, the activity of Src kinases alone is not sufficient for activation of c-Abl by PDGFR. Here we show that functional phospholipase C-gamma1 (PLC-gamma1) is required for c-Abl activation by PDGFR. Decreasing cellular levels of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) by PLC-gamma1-mediated hydrolysis or dephosphorylation by an inositol polyphosphate 5-phosphatase (Inp54) results in increased Abl kinase activity. c-Abl functions downstream of PLC-gamma1, as expression of kinase-inactive c-Abl blocks PLC-gamma1-induced chemotaxis towards PDGF-BB. PLC-gamma1 and c-Abl form a complex in cells that is enhanced by PDGF stimulation. After activation, c-Abl phosphorylates PLC-gamma1 and negatively modulates its function in vivo. These findings uncover a newly discovered functional interdependence between non-receptor Tyr kinase and lipid signalling pathways.

Citing Articles

SILAC Phosphoproteomics Reveals Unique Signaling Circuits in CAR-T Cells and the Inhibition of B Cell-Activating Phosphorylation in Target Cells.

Griffith A, Callahan K, King N, Xiao Q, Su X, Salomon A J Proteome Res. 2022; 21(2):395-409.

PMID: 35014847 PMC: 8830406. DOI: 10.1021/acs.jproteome.1c00735.

A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity : A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias.

Montecchini O, Braidotti S, Franca R, Zudeh G, Boni C, Sorio C Front Pharmacol. 2021; 12:749361.

PMID: 34867354 PMC: 8640483. DOI: 10.3389/fphar.2021.749361.

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling.

Tripathi R, Liu Z, Jain A, Lyon A, Meeks C, Richards D Nat Commun. 2020; 11(1):5463.

PMID: 33122628 PMC: 7596241. DOI: 10.1038/s41467-020-19075-3.

Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis.

Bannach C, Brinkert P, Kuhling L, Greune L, Schmidt M, Schelhaas M J Virol. 2020; 94(11).

PMID: 32188731 PMC: 7269448. DOI: 10.1128/JVI.02143-19.

EnABLing Tumor Growth and Progression: Recent progress in unraveling the functions of ABL kinases in solid tumor cells.

Tripathi R, Liu Z, Plattner R Curr Pharmacol Rep. 2019; 4(5):367-379.

PMID: 30746323 PMC: 6368175. DOI: 10.1007/s40495-018-0149-y.